FAQ
Who can apply for the program?
Organizations and institutions in eligible low income countries are invited to apply for participation in the GARDASIL Access Program.
Are there any prerequisites for participation in the program?
A letter of approval from the Ministry of Health is a prerequisite for participation in the GARDASIL Access Program.
How do I apply for the program?
Organizations and institutions in eligible low income countries who meet the GARDASIL Access Program eligibility criteria are invited to submit a vaccination program application. The application form can be downloaded from this website or requested by fax or email from the address below. The application will be reviewed by a team of experienced independent reviewers and the GARDASIL® Access Program Advisory Board.
The GARDASIL Access Program Advisory Board meets twice a year to review applications.
GARDASIL Access Program
Axios International
7, Boulevard de la Madeleine
75001 Paris
France
Phone: +33 144 860 760 ; Fax: +33 144 860 122
Email: GARDASILAccess@axiosint.com
When is the next application deadline?
Applications are accepted twice a year and deadlines can be found on the application page. Applicants who miss the deadline for proposal submission may wait for the next call, which will be announced on this website. Proposals received after the deadline will be kept until the next submission date.
How long does the review process take?
As soon as the application is received by Axios International, a screening will be performed to ensure that the information provided is complete. Applicants will be contacted within five days of receipt of their application. Additional information may be requested at this stage. If the application is complete, independent experts, commissioned by AHD, will review the application and give their recommendations to the Advisory Board. The Advisory Board will make a final review of the application/proposal at their bi-annual board meeting and give a recommendation to AHD. Thereafter, AHD notifies the institution of its inclusion in the GARDASIL Access Program or requests additional information or clarification to consider the institution for participation in the program.
How will I know if I receive the donation?
The applicant will receive an official letter to confirm that AHD has approved the organization or institution for inclusion in the GARDASIL Access Program. Details concerning the quantity of GARDASIL, timescale, shipping schedules and shipping procedures will be defined in the approval note. The applicant will be notified of shipment schedule as soon as the information is received from the shipper.
Are there any logistic requirements for the import of GARDASIL into my country?
The administration and use of GARDASIL requires the donation product to be approved for use in the country. If the vaccine is not approved for use, the applying institution must have a special import license and/or a waiver letter from the government to import this donation.
Who should I contact if I have any questions?
The GARDASIL Access Program manager is available for any questions you may have about the GARDASIL Access Program. Please see below for contact details.
GARDASIL Access Program
Axios International
7, Boulevard de la Madeleine
75001 Paris
France
Phone: +33 144 860 760 ; Fax: +33 144 860 122
Email: GARDASILAccess@axiosint.com
|
